Please login to the form below

Not currently logged in
Email:
Password:

Taiwan launches government-sponsored biotech incubator

The Supra Incubator Center (SIC) will focus on promoting the country's biotechnology sector

Taiwan has tapped executives from pharma company Roche and US regulator the Food and Drug Administration (FDA) to help set up a national biotech incubator.

The newly-launched Supra Incubator Center (SIC) will focus on promoting and fostering the development of the country's biotechnology sector.

“The primary purpose of our centre is to allocate resources to the nation's biotech industry and pharmaceutical companies, so that they can develop new and innovative biotech products,” SIC managing director Soo Whai-jen told Taiwan Today.

Soo, who has held senior R&D roles at Roche, Shire and Biogen, said the SIC would also provide Taiwan's biotech companies with legal counsel, help them with patent applications, and offer them technical assistance.

Soo will shortly be joined at SIC by Shaw Chen, who is currently deputy director of the US FDA's Office of Drug Evaluation.

The SIC's creation is part of Taiwan's “four pillars” strategy for developing its biotech industry.

The other elements of this saw the 2009 creation of the Taiwan Food and Drug, the launch of a $2bn biotech venture capital fund, and moves to provide financial support for research in genetic translation and the rapid prototyping production of medical devices.

2nd November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics